Indium-111 pentetreotide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Indium-111 pentetreotide, covering 2014-07-02 to 2014-07-02. Get the full timeline:
Most recent: Clinical Trial Update: Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer [Phase 1]